Li Zhixing, Chen Hanlin, Lv Jinglei, Zhao Renliang
Qingdao University Medical College, 38 Dengzhou Road, Qingdao 266000, China.
Department of Neurology, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, China.
Brain Res Bull. 2017 May;131:39-46. doi: 10.1016/j.brainresbull.2017.03.002. Epub 2017 Mar 8.
Ischemic stroke is a serious cerebrovascular disease that leads to death and/or severe disability, and extensive research has been directed in search of appropriate treatment measures. One such potential treatment is the use of cerebral ischemic post-conditioning (IPostC), and its neuroprotective effects and controllability have been widely confirmed and validated. Numerous studies have indicated that cerebral IPostC can suppress the inflammatory reaction in ischemia reperfusion injury, improve cerebral circulation, reduce infarct volume, and promote both neurogenesis and angiogenesis. The neuroprotective mechanisms underlying IPostC have been systematically studied, but still need a comprehensive summary and a more exhaustive understanding. Continuing research has proposed further applications of IPostC, including remote ischemic post-conditioning, pharmacologic ischemic post-conditioning, and delayed ischemic post-conditioning. However, most studies of IPostC are performed on animal models, and clinical studies are scarce. Therefore, future studies will need to focus on increasing our understanding of neuroprotective mechanisms underlying cerebral IPostC as well as accelerating its clinical translation.
缺血性中风是一种严重的脑血管疾病,可导致死亡和/或严重残疾,人们已开展了广泛研究以寻找合适的治疗措施。一种潜在的治疗方法是使用脑缺血后处理(IPostC),其神经保护作用和可控性已得到广泛证实和验证。大量研究表明,脑IPostC可抑制缺血再灌注损伤中的炎症反应,改善脑循环,减少梗死体积,并促进神经发生和血管生成。IPostC的神经保护机制已得到系统研究,但仍需要全面总结和更详尽的了解。持续的研究提出了IPostC的进一步应用,包括远程缺血后处理、药物性缺血后处理和延迟缺血后处理。然而,大多数关于IPostC的研究是在动物模型上进行的,临床研究很少。因此,未来的研究需要集中在增进我们对脑IPostC神经保护机制的理解以及加速其临床转化上。